These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35947797)

  • 1. Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients.
    Zaky M; Nordan T; Kapur NK; Vest AR; DeNofrio D; Chen FY; Couper GS; Kawabori M
    ASAIO J; 2023 Apr; 69(4):e158-e162. PubMed ID: 35947797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of heart transplantation in patients bridged with Impella 5.0: Comparison with native chest transplanted patients without preoperative mechanical circulatory support.
    Monteagudo-Vela M; Panoulas V; García-Saez D; de Robertis F; Stock U; Simon AR
    Artif Organs; 2021 Mar; 45(3):254-262. PubMed ID: 32936936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive biventricular mechanical circulatory support with Impella pumps as a bridge to heart transplantation: a first-in-the-world case report.
    Varian K; Xu WD; Lin W; Unai S; Tong MZ; Soltesz E; Krishnaswamy A; Kapadia S; Feitell S; Hanna M; Joyce E; Schoenhagen P; Starling RC; Taylor DO; Perez AL
    ESC Heart Fail; 2019 Jun; 6(3):552-554. PubMed ID: 30968544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    Saito S; Okubo S; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Takei Y; Tezuka M; Tsuchiya G; Konishi T; Shibasaki I; Ogata K; Fukuda H
    J Cardiol; 2024 Apr; 83(4):228-235. PubMed ID: 37926367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
    den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy.
    Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK
    Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
    Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
    Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary Left Ventricular Support Device as a Bridge to Heart-Liver or Heart-Kidney Transplant: Pushing the Boundaries of Temporary Support.
    Roach A; Emerson D; Megna D; Cole R; Catarino P; Salabat R; Ramzy D; Moriguchi J; Kobashigawa J; Trento A; Chikwe J; Esmailian F
    ASAIO J; 2023 Jan; 69(1):76-81. PubMed ID: 35544444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous flow left ventricular assist devices: a valid option for heart failure patients.
    Carrel T; Englberger L; Martinelli MV; Takala J; Boesch C; Sigurdadottir V; Gygax E; Kadner A; Mohacsi P
    Swiss Med Wkly; 2012; 142():w13701. PubMed ID: 23135811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock.
    Tokunaga C; Iguchi A; Nakajima H; Chubachi F; Hori Y; Takazawa A; Hayashi J; Asakura T; Yoshitake A
    BMC Cardiovasc Disord; 2022 Feb; 22(1):54. PubMed ID: 35172726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Impella 5.0 and extracorporeal left ventricular assist device in patients with cardiogenic shock.
    Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Okumura T; Shibata N; Kazama S; Kimira Y; Oishi H; Kuwayama T; Hiraiwa H; Usui A; Murohara T
    Int J Artif Organs; 2021 Nov; 44(11):846-853. PubMed ID: 34488481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients.
    Bidaut A; Flécher E; Nesseler N; Bounader K; Vincentelli A; Moussa M; Delmas C; Porterie J; Nubret K; Pernot M; Kindo M; Schneider C; Gaudard P; Rouvière P; Michel M; Sénage T; Boignard A; Chavanon O; Verdonk C; Para M; Maille B; Gariboldi V; Pozzi M; Hugon-Vallet E; Litzler PY; Anselme F; Blanchart K; Babatasi G; Bielefeld M; Grosjean S; Radu C; Hamon D; Bourguignon T; Genet T; Eschalier R; D'Ostrevy N; Nougue H; Martin AC; Vanhuyse F; Blangy H; Leclercq C; Martins RP; Galand V
    Crit Care Med; 2022 May; 50(5):e426-e433. PubMed ID: 34974497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ventricular assist devices as bridge to heart transplantation in cardiogenic shock or terminal heart failure--12 years experience at the Sheba Medical Center].
    Lavee J; Kassif Y; Freimark D; Har Zahav Y; Koman V; Preisman S; Smolinsky A; Raanani E
    Harefuah; 2007 Nov; 146(11):833-6, 911. PubMed ID: 18087826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
    Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally Invasive Direct Aortic Implantation of Impella 5.5 As Bridge to Transplant: A Case Report.
    Dichiacchio L; Heiler J; Kagawa H; Selzman CH; Goodwin ML
    Transplant Proc; 2024; 56(1):145-147. PubMed ID: 38171989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Toma C; Kilic A
    Clin Transplant; 2020 Mar; 34(3):e13818. PubMed ID: 32031274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impella 5.0 supported oncological surgery as bridge to LVAD.
    Montisci A; Micheletto G; Sibilio S; Donatelli F; Tespili M; Banfi C; Casilli F; Cosseta D; Miceli A; Cirri S; Pappalardo F
    ESC Heart Fail; 2021 Feb; 8(1):167-170. PubMed ID: 33161652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: De-escalate and ambulate.
    Bertoldi LF; Pappalardo F; Lubos E; Grahn H; Rybczinski M; Barten MJ; Legros T; Bertoglio L; Schrage B; Westermann D; Lapenna E; Reichenspurner H; Bernhardt AM
    J Crit Care; 2020 Jun; 57():259-263. PubMed ID: 32061461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Impella heart pump for management of women with peripartum cardiogenic shock.
    Elkayam U; Schäfer A; Chieffo A; Lansky A; Hall S; Arany Z; Grines C
    Clin Cardiol; 2019 Oct; 42(10):974-981. PubMed ID: 31436333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.
    Takeda K; Garan AR; Topkara VK; Kirtane AJ; Karmpaliotis D; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takayama H
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):591-596. PubMed ID: 27818380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.